Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThRIL: TR002 in Liver Transplantation
NCT02166177Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Jun 2014
- Primary completion
- Jan 2018
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of nadofaragene firadenovec in Liver transplant rejection, sponsored by Guy's and St Thomas' NHS Foundation Trust. Started Jun 2014; status: completed.
02
Drugs
nadofaragene firadenovec
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT02166177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166177.